Another study reported that pretreatment sPD-1 levels were not related to either PFS or OS for advanced NSCLC patients treated with ICIs either alone or together with cytotoxic chemotherapy (31). This evidence concerns the gene HOXD13 and non-small cell lung carcinoma.